NASDAQ$ROIV

Roivant Sciences Ltd · Q1 2027 earnings

Q1 2027 earnings · · Before market open · Investor relations

Briefing

Roivant Sciences Ltd reported its financial results for the first quarter ended June 30, 2026.

The company recorded revenue of $1.4 million and a net loss of $290.6 million for the quarter. Operating expenses increased year-over-year, driven by higher research and development and general and administrative costs. Cash, cash equivalents and marketable securities totaled approximately $3.8 billion at quarter end.

  • Revenue was $1.4 million for Q1 2027.
  • Net loss attributable to Roivant was $189.8 million.
  • R&D expenses totaled $202.0 million and G&A expenses totaled $165.5 million.
  • Cash position remained strong with $3.8 billion in cash, cash equivalents and marketable securities.

Headline financials

Total Revenue

$1.44M

Previous: $2.17M-33.5%
EPS (adj)

-$0.26

Previous: -$0.13-100.0%
General and administrative expenses

$166M

Previous: $134M+23.5%
Research and development expenses

$202M

Previous: $153M+32.1%
Net Income

-$291M

Previous: -$223M-30.1%
Operating Income

-$366M

Previous: -$285M-28.5%
Cash & Equivalents

$1.25B

No prior period
Total Assets

$5.31B

No prior period

Revenue & EPS history

Roivant Sciences · Revenue · Quarterly

$1.44M

Q1 2027-33.5%vs Q1 2026
Beat estimate in 7 of 15 quarters(47%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 18 quarterly earnings reports

Historical avg

+3.3%

Avg return

Earnings day

+1.0%

Avg return

5 days after

+1.0%

Avg return

30 days after

60%

12 / 20 earnings

Positive

+22.1%

Q3 2026

Best reaction

-5.5%

Q1 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2027
Q4 2026+14.9%+6.2%+11.4%
Q3 2026+22.1%+26.8%+36.1%
Q2 2026+2.6%-1.6%-1.8%
Q1 2026-2.8%+3.1%+19.8%
Q4 2025+6.4%+5.9%+7.3%
Q4 2024-3.4%+0.0%-1.5%
Q3 2024+4.1%+6.6%-5.9%
Q2 2024+5.6%+1.8%+22.7%
Q1 2024-5.2%-6.1%-3.5%
Q4 2023+9.4%+7.8%+28.8%
Q3 2023+9.7%+8.2%+7.8%
Q2 2023+7.4%-3.1%+39.9%
Q1 2023-5.5%-15.3%-15.8%
Q4 2022-4.1%-5.6%-11.8%
Q3 2021+5.1%-3.2%-25.4%
Q3 2022+5.4%-3.2%-25.4%
Q2 2022-2.4%-4.8%+6.8%
Q2 2021-3.8%-4.8%+6.8%
Q1 2021+0.1%+0.7%-38.7%
Q1 2022+0.0%+0.7%-38.7%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro